Our Mission: Looking after your sight

Optina Diagnostics’ mission is to develop innovative diagnostic tools for the early detection of diseases threatening the vision such as age-related macular degeneration (ARMD), diabetic retinopathy (DR) and glaucoma.

Early diagnostic is the key to save vision!

In North America alone, millions of people live with varying degrees of irreversible vision-loss due to eye diseases affecting the retina or optic nerve, the 3 most important being glaucoma, ARMD and DR. The retina is the thin light-sensitive layer at the back of the eye that acts like a photographic film and transmits the information via the optic nerve to the brain for interpretation. At the center of the retina is the macula, a small region responsible for color and detailed vision. When the macula is affected by a disease, such as ARMD or DR, vision is immediately reduced. Similarly, vision loss also occurs when the optic nerve is damaged by glaucoma for example. In all cases, however, with early detection and treatments, it is usually possible to protect your eyes against serious vision loss.

Seeing signs of the disease before it is too late!

Today, most retinal diseases cannot be diagnosed prior structural changes have been observed in the eye. Unfortunately, irreversible damage have already occurred to the eye once these changes are visible. Optina Diagnostics, through its unique hyerspectral technology (link to technology), aims to detect the molecular signs of the disease before anatomical changes are apparent and prevent vision loss.

Looking into the future

The eye represents a great window to look at the vasculature (retinal vessels) and nervous system (optic nerve head) present at the back of the eye. Signs of systemic cardiovascular and neuronal pathologies could therefore also be observed non-invasively.